A
Alexandar Tzankov
Researcher at University Hospital of Basel
Publications - 468
Citations - 20741
Alexandar Tzankov is an academic researcher from University Hospital of Basel. The author has contributed to research in topics: Diffuse large B-cell lymphoma & Lymphoma. The author has an hindex of 56, co-authored 414 publications receiving 15162 citations. Previous affiliations of Alexandar Tzankov include University of Basel & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Inflammation and vascular remodeling in COVID-19 hearts
Christopher Werlein,Maximilian Ackermann,Helge Stark,Harshit R. Shah,Alexandar Tzankov,Jasmin D. Haslbauer,Saskia von Stillfried,Roman D. Bülow,Ali El-Armouche,Stephan R. Kuenzel,Jan-Lukas Robertus,Marius Reichardt,Axel Haverich,Anne Höfer,Lavinia Neubert,Edith Plucinski,Peter Braubach,Stijn E. Verleden,Tim Salditt,Nikolaus Marx,Tobias Welte,Johann Bauersachs,Hans Kreipe,Steven J. Mentzer,P. K. Ilja Boor,Stephen M. Black,Florian Länger,Mark Kuehnel,Danny Jonigk +28 more
TL;DR: In this paper , the authors performed a comprehensive analysis of heart samples from 24 autopsies with confirmed SARS-CoV-2 infection and compared them to samples of age-matched Influenza H1N1 A (n = 16), lymphocytic non-influenza myocarditis cases and non-inflamed heart tissue.
Journal ArticleDOI
Retrospective Post-mortem SARS-CoV-2 RT-PCR of Autopsies with COVID-19-Suggestive Pathology Supports the Absence of Lethal Community Spread in Basel, Switzerland, before February 2020.
Jasmin D. Haslbauer,Valeria Perrina,Matthias S. Matter,Athanassios Dellas,Michael J. Mihatsch,Alexandar Tzankov +5 more
TL;DR: The data suggest the absence of early lethal community spread of COVID-19 in Basel before its initial reported emergence in Switzerland in March 2020.
Journal ArticleDOI
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Angela M Araujo,A. Abaurrea,Peio Azcoaga,Joanna I. López-Velazco,Sara Suárez-Manzano,Javier Eduardo Rengifo Rodriguez,R Rezola,Leire Egia-Mendikute,Fatima Valdes-Mora,Juana M. Flores,Liam Jenkins,Laura Pulido,Iñaki Osorio-Querejeta,Patricia Fernández-Nogueira,Nicoletta Ferrari,C Sales Viera,Natalia Martín-Martín,Alexandar Tzankov,Serenella Eppenberger-Castori,Isabel Álvarez-López,Ander Urruticoechea,Paloma Bragado,Nicholas Coleman,Asis Palazon,Arkaitz Carracedo,David Gallego-Ortega,Fernando Calvo,Clare M. Isacke,María M. Caffarel,Charles H. Lawrie +29 more
TL;DR: Evidence is provided of the role of the cytokine oncostatin M (OSM) as central node for multicellular interactions between immune and nonimmune stromal cells and the epithelial cancer cell compartment and support the notion that theStromal OSM/OSMR axis reprograms the immune andnonimmune microenvironment and plays a key role in breast cancer progression.
Journal ArticleDOI
Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas.
Sylvia Hoeller,Michel Bihl,Deborah Zihler,Sergio Cogliatti,Maurilio Ponzoni,Andreas Zettl,Philip Went,Anja Foerster,Petra Hirschmann,Alexandar Tzankov,Stephan Dirnhofer +10 more
TL;DR: BCL- 2-negative follicular lymphoma did not show a BCL-2 break on the genetic level and showed both increased apoptotic and proliferation rates compared with BCLs-2-positive follicle lymphoma, and the network of follicular dendritic cells showed a well-defined and strongly developed follicularDendritic cell network.
Journal ArticleDOI
The international consensus classification of mastocytosis and related entities
TL;DR: This review article focuses on the updates in mastocytosis of the 2022 international consensus classification (ICC).